52629-53-5

Upstream product

• 623-03-0 4-Cyanochlorobenzene 
• 1467-05-6 4-ethylbenzylchloride 
• 52629-43-3 4-Ethylphenylessigsaeurechlorid 
• 108-90-7 chlorobenzene 

Downstream Products

• 782483-57-2 4-(4-chloro-phenyl)-5-(4-ethyl-phenyl)-thiazol-2-ylamine 

Relevant academic research and scientific papers

SUBSTITUTED PHENYLALKANOIC ACIDS

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I), which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosin

Substituted phenylalkanoic acids for the treatment of diabetes

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance or hyperglycemia. These compounds include inhibitors of protein tyrosine phosphatase (PTP-1B) that are useful in the treatment of diabetes and other PTP-1B mediated diseases, such as cancer, neurodegenerative diseases and the like. The compounds of the invention are also useful in pharmaceutical compositions and methods of treating the aforementioned conditions.